Back Article

  • Barbosa A S, Lin C J. Gene silencing with RNA interference: a novel tool for the study of physiology and pathophysiology of adrenal cortex[J]. Arq Bras Endocrinol Metabol, 2004, 48(5): 612-619. doi: 10.1590/S0004-27302004000500005

  • Bang S, Jeong E J, Kim I K. Fas and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction[J]. J. Biol. Chem, 2000, 275(): 36217-36222. doi: 10.1074/jbc.M006620200

  • Chan F K, Lenardo M J. A crucial role for p80 TNFR2 in amplifying p60 TNFR1 apoptosis signals in T raves DT[J]. Apoptotic effects of LPS on fibroblasts are indirectly mediated through TNFR1. J Dent Res, 2004, 83(9): 671-676.

  • Cheng V C, Lo C M, Lau G K. Current issues and treatment of fulminant hepatic failure including transplantation in Hong Kong and the Far East[J]. Semin. Liver Dis, 2003, 23(): 239-250. doi: 10.1055/s-2003-42642

  • Costelli P, Aoki P, Zingaro B. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody[J]. Cell Death Differ, 2003, 10(9): 997-1004. doi: 10.1038/sj.cdd.4401281

  • Elbashir S M, Harborth J, Lendeckel W. Duplexes of 21-nucleotide RNAs mediate RNA in-terference in cultured mammalian cells[J]. Nature, 2001, 411(): 494-498. doi: 10.1038/35078107

  • Jacque J M, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference[J]. Nature, 2002, 418(6896): 435-438. doi: 10.1038/nature00896

  • Kapadia S B, Brideau-Andersen A, Chisari F V. Interference of hepatitis C virus RNA replication by short interfering RNAs[J]. Proc Natl Acad Sci USA, 2003, 100(): 2014-2018. doi: 10.1073/pnas.252783999

  • Ledgerwood E C, Pober J S, Bradley J R. Recent advances in the molecular basis of TNF signal trans-duction[J]. Lab. Invest, 1999, 79(): 1040-1050.

  • Nagaki M, Iwai H, Naiki T. High levels of serum interleukin and tumor necrosis factor alpha are associated with fatality in fulminant hepatitis[J]. J Infect Dis, 2000, 182(4): 1103-1108. doi: 10.1086/jid.2000.182.issue-4

  • Pfeffer K T, Matsuyama T M, Kundig A. Mice deficient for the 55-kD tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L[J]. monocytogenes infection. Cell, 1993, 73(): 457-.

  • Reynolds A, Leake D, Boese Q. Rational siRNA design for RNA interference[J]. Nat Biotechnol, 2004, 22(3): 326-330. doi: 10.1038/nbt936

  • Schomber T, Kalberer C P, Wodnar-Filipowicz A. Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells[J]. Blood, 2004, 103(): 4511-4513. doi: 10.1182/blood-2003-07-2397

  • Song E, Lee S K, Wang J. RNA interference targeting Fas protects mice from fulminant hepatitis[J]. Nat Med, 2003, 9(3): 347-351. doi: 10.1038/nm828

  • Varfolomeev E E, Boldin M P, Goncharov T M. A potential mechanism of 'cross-talk' between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other[J]. J. Exp, 1996, 183(): 1271-1275. doi: 10.1084/jem.183.3.1271

  • Zhu C L, Sun Y, Yan W M. Novel mfgl2 antisense plasmid inhibits mfgl2 expression and ameliorates MHV-3 induced fulminant hepatitis in Balb/cJ mice[J]. Human Gene Therapy, 2006, 17(): 589-600. doi: 10.1089/hum.2006.17.589

  • Zaehres H, Lensch M W, Daheron L. High-efficiency RNA interference in human embryonic stem cells[J]. Stem Cells, 2005, 23(3): 299-305. doi: 10.1634/stemcells.2004-0252